For life sciences companies preparing for potential acquisition or investment, intellectual property (IP) often represents the cornerstone of your value, making thorough preparation and strategic foresight essential for...more
4/30/2025
/ Acquisitions ,
Artificial Intelligence ,
Due Diligence ,
Intellectual Property Protection ,
Investors ,
IP License ,
Life Sciences ,
Mergers ,
Patents ,
Pharmaceutical Patents ,
Strategic Planning
AI is vaulting drug discovery forward leaps and bounds—and now regulators are beginning to catch up, with the United States Patent and Trademark Office recently issuing new guidelines on the patentability of AI-assisted...more
Inventors are generally counseled to file a patent application as soon as they have a patentable invention to avoid potential forfeiture of important rights in today’s first inventor-to-file system. However,...more